Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Amorfix Life Science

(OTHER OTC: ARFXF)
Add to Portfolio
-0.0001 (-0.06%)
as of Sep 20, 2019

Last 0.1747
Change -0.0001 (-0.06%)
Open 0.1700
Prev. Close 0.1748
Today's Range
0.1646
0.1747
52wk Range
0.1381
0.3356
Volume 21,600
Avg Volume 93,050
Sector All Sectors By Industry

Perfomance Comparison

Name Today 3-Month 1-Year
ARFXF -0.06% +3.01% -24.04%
DJIA -0.59% -0.56% +1.04%
S&P 500 -0.49% -0.26% +2.09%

Key Statistics

Annual EPS -0.0400
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 45,690
Weighted Alpha -31.74
Standard Deviation -0.01
Profit Margin N/A
Beta -0.2400

Growth Rates

YTD -12.17%
1-Year -24.89%
3-Year +74.53%
5-Year -36.22%
10-Year -84.79%

Opinion

Sell Hold Buy

Recent Headlines

ProMIS Neurosciences Executive Chairman Eugene

Globe Newswire via COMTEX - Mon Sep 16, 07:30AM EDT
TORONTO and CAMBRIDGE, Mass., Sept. 16, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oli(full story)
ARFXF: 0.1747 (-0.0001), PMN.TO: 0.23 (unch)

ProMIS Neurosciences to Present at H.C. Wainwright

Globe Newswire via COMTEX - Tue Sep 03, 07:30AM EDT
Company to showcase its innovative Alzheimer's, Parkinson's and ALS programs(full story)
ARFXF: 0.1747 (-0.0001), PMN.TO: 0.23 (unch)

ProMIS Neurosciences to Present at HC Wainwright

PR Newswire via COMTEX - Tue Sep 03, 07:30AM EDT
Company to showcase its innovative Alzheimer's, Parkinson's and ALS programs(full story)
ARFXF: 0.1747 (-0.0001), PMN.TO: 0.23 (unch)

ProMIS Neurosciences Appoints Internationally

Globe Newswire via COMTEX - Tue Aug 27, 07:30AM EDT
TORONTO and CAMBRIDGE, Mass., Aug. 27, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic olig(full story)
ARFXF: 0.1747 (-0.0001), PMN.TO: 0.23 (unch)

ProMIS Neurosciences Announces Second Quarter 2019

Globe Newswire via COMTEX - Tue Aug 13, 07:30AM EDT
Company continues to expand its portfolio of highly selective antibodies targeting root cause of Alzheimer's, ALS and Parkinson's disease(full story)
ARFXF: 0.1747 (-0.0001), PMN.TO: 0.23 (unch)